Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome
Authors
Keywords
Pancreatic cancer, Differentiated tumors, Cancer detection and diagnosis, Cell staining, Negative staining, Cell proliferation, Pancreatitis, Nuclear staining
Journal
PLoS One
Volume 11, Issue 3, Pages e0151635
Publisher
Public Library of Science (PLoS)
Online
2016-03-19
DOI
10.1371/journal.pone.0151635
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
- (2015) Paul Kachel et al. BMC CANCER
- Cancer Metabolism: Targeting metabolic pathways in cancer therapy
- (2015) Shree Ram Singh et al. CANCER LETTERS
- PKM2 contributes to cancer metabolism
- (2015) Nicholas Wong et al. CANCER LETTERS
- LDH-A Acetylation: Implication in Cancer
- (2015) Di Zhao et al. Oncotarget
- PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
- (2015) Wei-Ren Liu et al. Oncotarget
- A Novel KLF4/LDHA Signaling Pathway Regulates Aerobic Glycolysis in and Progression of Pancreatic Cancer
- (2014) M. Shi et al. CLINICAL CANCER RESEARCH
- Synthesis, cytotoxicity for mimics of catalase: Inhibitors of lactate dehydrogenase and hypoxia inducible factor
- (2014) Juan-Juan Xue et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pyruvate kinase M2 and cancer: an updated assessment
- (2014) Mohd Askandar Iqbal et al. FEBS LETTERS
- Activators of PKM2 in cancer metabolism
- (2014) Steven L Warner et al. Future Medicinal Chemistry
- Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients
- (2014) C. A. Crane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment
- (2014) Yaping Yu et al. World Journal of Surgical Oncology
- PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer
- (2013) J. Li et al. Clinical & Translational Oncology
- Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapy
- (2013) Ping Miao et al. IUBMB LIFE
- Targeting lactate metabolism for cancer therapeutics
- (2013) Joanne R. Doherty et al. JOURNAL OF CLINICAL INVESTIGATION
- PKM2 Regulates Chromosome Segregation and Mitosis Progression of Tumor Cells
- (2013) Yuhui Jiang et al. MOLECULAR CELL
- Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma
- (2013) Xuelin Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- Lactate Dehydrogenase A Expression Is Necessary to Sustain Rapid Angiogenesis of Pulmonary Microvascular Endothelium
- (2013) Glenda Parra-Bonilla et al. PLoS One
- JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1 -mediated glucose metabolism
- (2013) H.-J. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells
- (2013) Yefei Rong et al. TUMOR BIOLOGY
- Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer
- (2012) Dipok Kumar Dhar et al. CANCER
- Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
- (2012) A. Le et al. CLINICAL CANCER RESEARCH
- Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells
- (2012) Cheng-Fu Zhou et al. IUBMB LIFE
- Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
- (2012) Sophie Gourgou-Bourgade et al. JOURNAL OF CLINICAL ONCOLOGY
- ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
- (2012) Weiwei Yang et al. NATURE CELL BIOLOGY
- Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
- (2012) Dimitrios Anastasiou et al. Nature Chemical Biology
- Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer
- (2012) Jae Yun Lim WORLD JOURNAL OF GASTROENTEROLOGY
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
- (2010) Sybille Mazurek INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Comparison of Plasma Tu-M2-PK and CA19-9 in Pancreatic Cancer
- (2010) Maiken Thyregod Joergensen et al. PANCREAS
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
- (2010) A. Le et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines
- (2010) Yogesh Kumar et al. TUMOR BIOLOGY
- Identification of small molecule inhibitors of pyruvate kinase M2
- (2009) Matthew G. Vander Heiden et al. BIOCHEMICAL PHARMACOLOGY
- Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma
- (2009) Y.G. Li et al. DIGESTIVE AND LIVER DISEASE
- Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply
- (2009) Gilles A. Spoden et al. EXPERIMENTAL CELL RESEARCH
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
- (2009) T. Hitosugi et al. Science Signaling
- Predominant infiltration of macrophages and CD8+T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
- (2008) Osamu Kawai et al. CANCER
- Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy
- (2008) Philip D Hardt et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started